238 related articles for article (PubMed ID: 22198284)
1. p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.
Vaughan CA; Singh S; Windle B; Sankala HM; Graves PR; Andrew Yeudall W; Deb SP; Deb S
Arch Biochem Biophys; 2012 Feb; 518(1):79-88. PubMed ID: 22198284
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived p53 mutants induce NF-kappaB2 gene expression.
Scian MJ; Stagliano KE; Anderson MA; Hassan S; Bowman M; Miles MF; Deb SP; Deb S
Mol Cell Biol; 2005 Nov; 25(22):10097-110. PubMed ID: 16260623
[TBL] [Abstract][Full Text] [Related]
4. Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter.
Vaughan CA; Pearsall I; Singh S; Windle B; Deb SP; Grossman SR; Yeudall WA; Deb S
Oncotarget; 2016 Mar; 7(11):12426-46. PubMed ID: 26820293
[TBL] [Abstract][Full Text] [Related]
5. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.
Barlev NA; Liu L; Chehab NH; Mansfield K; Harris KG; Halazonetis TD; Berger SL
Mol Cell; 2001 Dec; 8(6):1243-54. PubMed ID: 11779500
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3.
Vincek AS; Patel J; Jaganathan A; Green A; Pierre-Louis V; Arora V; Rehmann J; Mezei M; Zhou MM; Ohlmeyer M; Mujtaba S
Molecules; 2018 Aug; 23(8):. PubMed ID: 30072621
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.
Vaughan CA; Singh S; Grossman SR; Windle B; Deb SP; Deb S
Mol Oncol; 2017 Jun; 11(6):696-711. PubMed ID: 28423230
[TBL] [Abstract][Full Text] [Related]
8. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters.
Dell'Orso S; Fontemaggi G; Stambolsky P; Goeman F; Voellenkle C; Levrero M; Strano S; Rotter V; Oren M; Blandino G
OMICS; 2011 May; 15(5):305-12. PubMed ID: 21332394
[TBL] [Abstract][Full Text] [Related]
9. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.
Zhu J; Sammons MA; Donahue G; Dou Z; Vedadi M; Getlik M; Barsyte-Lovejoy D; Al-awar R; Katona BW; Shilatifard A; Huang J; Hua X; Arrowsmith CH; Berger SL
Nature; 2015 Sep; 525(7568):206-11. PubMed ID: 26331536
[TBL] [Abstract][Full Text] [Related]
10. The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein.
Liu G; Xia T; Chen X
J Biol Chem; 2003 May; 278(19):17557-65. PubMed ID: 12609999
[TBL] [Abstract][Full Text] [Related]
11. Differential contribution of p300 and CBP to regulatory element acetylation in mESCs.
Martire S; Nguyen J; Sundaresan A; Banaszynski LA
BMC Mol Cell Biol; 2020 Jul; 21(1):55. PubMed ID: 32690000
[TBL] [Abstract][Full Text] [Related]
12. BRD7 is a candidate tumour suppressor gene required for p53 function.
Drost J; Mantovani F; Tocco F; Elkon R; Comel A; Holstege H; Kerkhoven R; Jonkers J; Voorhoeve PM; Agami R; Del Sal G
Nat Cell Biol; 2010 Apr; 12(4):380-9. PubMed ID: 20228809
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene.
Hiroi M; Ohmori Y
J Biol Chem; 2003 Jan; 278(1):651-60. PubMed ID: 12403783
[TBL] [Abstract][Full Text] [Related]
14. p53 induces distinct epigenetic states at its direct target promoters.
Vrba L; Junk DJ; Novak P; Futscher BW
BMC Genomics; 2008 Oct; 9():486. PubMed ID: 18922183
[TBL] [Abstract][Full Text] [Related]
15. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
16. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-Function Activity of Mutant p53 in Lung Cancer through Up-Regulation of Receptor Protein Tyrosine Kinase Axl.
Vaughan CA; Singh S; Windle B; Yeudall WA; Frum R; Grossman SR; Deb SP; Deb S
Genes Cancer; 2012 Jul; 3(7-8):491-502. PubMed ID: 23264849
[TBL] [Abstract][Full Text] [Related]
18. Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.
Di Agostino S; Strano S; Emiliozzi V; Zerbini V; Mottolese M; Sacchi A; Blandino G; Piaggio G
Cancer Cell; 2006 Sep; 10(3):191-202. PubMed ID: 16959611
[TBL] [Abstract][Full Text] [Related]
19. Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway.
Perez RE; Knights CD; Sahu G; Catania J; Kolukula VK; Stoler D; Graessmann A; Ogryzko V; Pishvaian M; Albanese C; Avantaggiati ML
J Cell Physiol; 2010 Nov; 225(2):394-405. PubMed ID: 20589832
[TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.
Schumm K; Rocha S; Caamano J; Perkins ND
EMBO J; 2006 Oct; 25(20):4820-32. PubMed ID: 16990795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
